31 results
DEF 14A
ALGS
Aligos Therapeutics Inc
27 Apr 21
Definitive proxy
4:15pm
of Board in Risk Oversight Process
Board Committees
Meetings of the Board of Directors, Board and Committee Member Attendance and Annual Meeting Attendance … responsibility for our financial statements and reporting processes, including our systems of internal controls. In fulfilling its oversight
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
oversight responsibilities, the Audit Committee reviewed and discussed with management Aligos’ audited financial statements as of and for the year … Oversight Board (the “PCAOB”). In addition, the Audit Committee has received the written disclosures and the letter from EY required by PCAOB Ethics
S-1
jlmyn9v
25 Sep 20
IPO registration
5:27pm
424B4
85e4s5 hk1fz
19 Oct 20
Prospectus supplement with pricing info
5:21pm
DRS
8yu6yo 74
26 Aug 20
Draft registration statement
12:00am
S-1
EX-10.3
h5ttq1mlmd69
25 Sep 20
IPO registration
5:27pm
10-K
d906i9gqxwo08iuqbt
23 Mar 21
Annual report
4:26pm
8-K
EX-10.1
93m4dcl
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
S-3
EX-1.2
61er4rn
4 Nov 21
Shelf registration
4:57pm